New SEC Form D filing

Theravie Pharma, Inc., 2026-10-19

A new SEC Form D private-offering notice from San Diego, CA, a $2,250,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Theravie Pharma, Inc. site↗ Verified via SEC Form D

Biotech developing a safer oral treatment for moderate to severe acne, spun out of UC San Diego research

Filed 4 days agoFiled to raise $2,250,000First money in 2026-09-29Raised so far $750,000HQ (as filed) San Diego, CASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified theravie-pharma.com↗Named in the filing 2 executives & directors
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source